ALICE KUFS: Open Payments
NPI 1205901618 · LEVITTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,637 in 44 payments from 12 companies in 2025. Trend: 2023 $1,231 · 2024 $1,465 · 2025 $1,637
Food & beverage: $1,637
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $561 |
| AstraZeneca Pharmaceuticals LP | 5 | $470 |
| GlaxoSmithKline, LLC. | 5 | $114 |
| Optinose US, Inc. | 5 | $109 |
| Grifols USA, LLC | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| GENZYME CORPORATION | 4 | $82 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: DUPIXENT, BREZTRI, AIRSUPRA, Xhance, NUCALA, Xembify, Rhapsido, INSPIRE.
Industry payments across NY — which companies pay providers there.
